Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Processes-for-the-synthesis-of-oligomeric-compounds

 Antisense modulation of stat3 expression
OF THE INVENTION STAT3 plays an important role in cytokine signal transduction. Overexpression and/...


 Cold-active beta-galactosidase, the process for its preparation and the use thereof
The object of the present invention is to hydrolyse lactose by using a .beta.-galactosidase, which ...


 Method of delivering powder transdermally with needless injector
What we claim is: 1. A method of therapeutic treatment, comprising transdermally delivering ...


 Telomere repeat binding factors and diagnostic and therapeutic use thereof
The present invention provides vertebrate telomeric binding factors (TRFs) that bind to the TTAGGG ...


 Protease-activated receptor PAR4 (ZCHEMR2)
What is claimed is: 1. An isolated polynucleotide molecule that encodes a polypeptide comprising ...


 Systemic drug delivery compositions comprising a polycationi substance
I claim: 1. A method of systemically delivering a pharmaceutically effective amount of a ...


 Nucleic acid-containing composition, its preparation and use
We claim: 1. A composition comprising a deoxyribonucleic acid and a cationic oligopeptide that ...


 Peptide-enhanced cationic lipid transfections
OF THE INVENTION The present invention provides improved methods for transfecting eukaryotic cells ...


 Controlled release formulations coated with aqueous dispersions of acrylic polymers
It is therefore an object of the present invention to provide a controlled release formulation of a ...


 Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
What is claimed is: 1. A compound having the formula I: ##STR5## wherein, R.sub.1 is OH, O--R.sub.3,...


 Processes for the synthesis of oligomeric compounds

Details
Inventors: Manoharan, Muthiah;
Assignee: Isis Pharmaceuticals, Inc. (Carlsbad, CA)
Primary Examiner: Geist; Gary
Assistant Examiner:
Attorney, Agent or Firm: Woodcock Washburn Kurtz Mackiewicz & Norris LLP

The present invention provides synthetic processes by which oligomeric compounds, having at least one phosphodiester or phosphorothioate linkage, are prepared. The synthetic processes use a novel mixture of concentrated ammonium hydroxide and a thiol compound during the deblocking step of all or selected internucleoside linkages. Alternatively, the deblocking is carried out in two steps using a mercapto compound in an aqueous amine followed by concentrated ammonium hydroxide. Also provided are synthetic intermediates useful in such processes. Novel oxidation procedures to give phosphodiester oligomers are also included.

DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS The present invention provides methods for the preparation of oligomeric compounds having at least one phosphodiester or phosphorothioate internucleoside linkage.
Oligomeric compounds of the invention are prepared using a novel deprotection step to form phosphodiester or phosphorothioate internucleoside linkages.
The methods utilize an O-allyl phosphorus protecting group on one or all of the internucleoside linkages prior to the deprotection step.
This allyl protecting group is cleaved in a deblocking step using an aqueous solution of concentrated ammonium hydroxide having a thiol compound present in the solution.
As used herein, the term "oligomeric compound" refers to compounds containing a plurality of nucleoside monomer subunits that are joined by internucleoside linkages.
Preferred internucleoside linkages include phosphorus-containing linkages, such as phosphite, phosphodiester, phosphorothioate, and/or phosphorodithioate linkages.
The term "oligomeric compound," therefore, includes naturally-occurring oligonucleotides, their analogs, and synthetic oligonucleotides.
The methods of the present invention are useful for the preparation of oligomeric compounds containing monomeric subunits that are joined by a variety of linkages.
In a preferred embodiment of the invention oligomers are synthesized such that all internucleoside linkages bear an allyl protecting group that is amenable to deblocking in a single step with concentrated ammonium hydroxide having a mercapto compound present in the solution.
In some preferred embodiments, a first monomer attached to a solid support is elongated using P--O-allyl monomers or a mixture of P--O-allyl phosphoramidite monomers and other monomers such as .
beta.
-cyanoethyl phosphoramidite monomers.
The methods of the present invention have been used with automated DNA synthesizers to synthesize oligomeric compounds of desired length and sequence.
Some oligomeric compounds have been synthesized using only P--O-allyl phosphoramidite monomers



Related patents
  Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
OF THE INVENTION Usually, in the method of synthesis of the radiolabelled platinum chemotherapeutic agent the step of converting the metal halide into a radiolabelled ...
  Pharmaceutical composition for diabetic neuropathy
What is claimed is: 1. A method for the prophylaxis of diabetic peripheral neuropathy, which comprises administering an effective amount of cytidine 5'-diphosphocholine ...
  Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
This invention aids in fulfilling this need in the art by providing an in vitro, single cycle, recombinant virus assay (RVA) for determining inhibition of HIV ...
  Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance
OF THE INVENTION The present invention relates to new and useful methods including methods for detecting HIV, methods for detecting HIV drug resistance, methods for ...
  Continuous process for ethanol production by bacterial fermentation
The accompanying FIGURE will provide a background for the following discussion in which the method and apparatus for carrying out this invention are described in detail....
  Stable solution of hyaluronate in a balanced salt medium
What is claimed is: 1. A physiological visco-elastic formulation consisting of sodium hyaluronate in an amount in the range of about 0.1% to about 5% by weight in a ...
  Radiolabeled fusion toxins for cancer therapy
The present invention describes the synthesis and purification of a new class of compounds known as radiolabeled fusion toxins (RFT), in which both toxin and ...
  Genetically modified cells expressing a TGF.beta. inhibitor, the cells being lung cancer cells
OF THE PREFERRED EMBODIMENT Lung cancers account for 30% of all death due to cancer in the United States (Ramanathan and Belani, 1997). The overall cure rate for lung ...
  Auto-ligating oligonucleotide compounds
OF THE INVENTION The invention relates to a method and compositions for in situ formation of an effective antisense compound or probe on a target polynucleotide. C...
  Nucleic acids encoding transcription factor APRF (acute phase response factor)
What is claimed: 1. An isolated DNA molecule which encodes a human APRF polypeptide having the amino acid sequence of SEQ ID No:1. 2. An isolated DNA molecule comprising ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved